IFNG and neoplasm: Similarly, in HCT15 tumor-bearing mice, AT-II combined with IFN-γ exhibited superior efficacy in suppressing tumor growth and lung metastasis, with tumor growth inhibition rates 1.5-fold and 2-fold higher than either treatment alone [57].